The company, which is helping create a COVID-19 treatment, is exploring a possible initial public offering in the U.S., aiming to raise $200 million to $300 million, according to Reuters’ sources. The insiders say the company has hired several parties as the lead underwriters, and plans to submit a filing within weeks. (Reuters)
Skip to content
The company, which is helping create a COVID-19 treatment, is exploring a possible initial public offering in the U.S., aiming to raise $200 million to $300 million, according to Reuters’ sources. The insiders say the company has hired several parties as the lead underwriters, and plans to submit a filing within weeks. (Reuters)
Talking point: The company was considering listing as early as November, it said in July, with CEO Carl Hansen saying it initially planned on going public in a year or two, but investment bankers touting favourable market conditions for companies in the biotech space were advising it to act earlier. Nearly half of American IPOs this year have been from the health-care sector, according to IPOScoop. The company recently announced it had started Phase 3 clinical trials for a possible coronavirus treatment it is working on with several partners, including Eli Lilly.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
News
Bay Street backs Canada’s AI strategy, but warns the devil is in the details
Briefing
Cenovus’s Jon McKenzie says there’s no financial case for a new pipeline and major carbon capture
Ubisoft shuts down Winnipeg studio
Quebec invested over $760M in battery companies that eventually went under, report says
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
